MiaMed Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

MiaMed General Information

Description

Developer of brain disorder medicines. The company provides research and development services for cyclin-dependent kinase-like 5 focused on treatment of brain disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Amicus Therapeutics
Primary Office
  • 641 Lexington Avenue
  • 15th Floor
  • New York, NY 10022
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MiaMed Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MiaMed‘s full profile, request access.

Request a free trial

MiaMed Executive Team (1)

Name Title Board Seat Contact Info
Michael Jasulavic Chief Executive Officer & President
To view MiaMed’s complete executive team members history, request access »